TheEdgeResearch
Home / Stocks / ACGJ

ACI Global Corporation (ACGJ)

OTC Healthcare Medical - Pharmaceuticals
$0.00 ▼ -100.00%
Market Cap
$324
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Beta
339.66
52-Wk Range
1.0E-6-1.0E-6
CEO
Michael Howarth
Country
US
Currency
USD

ACI Global Corporation operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in US. The stock last traded at $0.00, down 100.00% on the session, giving a market capitalisation of $324. Its beta of 339.66 implies it has historically moved more than the broad market.

Company profile
Exchange
Other OTC
Employees
IPO date
2023-08-07
Headquarters
US
About ACI Global Corporation

ACI Global Corporation is a nascent enterprise currently in its developmental phase. Operating through its various subsidiaries, the company specializes in inventing and refining a proprietary technology. This innovative process is designed for the creation of synthetic rubber powder and thermoplastic elastomers, which are marketed under the "Micropowder" brand name, primarily within the United States. ACI Global aims to apply this Micropowder technology to the chemical formulation and manufacturing of rubbers and elastomers, with key applications envisioned for the tire and plastics industries. Founded in 1997, ACI Global maintains its principal office in Greenwich, Connecticut.

Comparable companies

ACI Global Corporation is most often compared with the following Healthcare names:

ALNAQARTHIMVIQINDRMICRDMYHIPECNRGBOQSYNITGVN
More research on ACGJ
ACGJ technical analysis ACGJ TheEdge Score Compare against peers
Open full interactive analysis & DCF →